TINJAUAN HUKUM ISLAM TERHADAP FATWA MUI NO 02 TAHUN 2021 TENTANG KEHALALAN VAKSIN COVID-19 SINOVAC
DOI:
https://doi.org/10.29103/jimfh.v5i2.8230Abstract
The determination of various types of Covid-19 vaccine products that have been determined by the Indonesian government as well as promises to provide Covid-19 vaccine products cannot be guaranteed to be halal, thayib and safe to use, especially for Indonesian people who are Muslim. On this basis, there was a debate in Indonesia regarding the halalness of the
covid 19 vaccine. Therefore, in order to organize and be able to successfully distribute the vaccine, as well as the consumption of the vaccines that have been purchased. So the Indonesian government cooperates with the Indonesian Ulema Council (MUI) by referring to the Fatwa of the Indonesian Ulema Council (MUI) NO. 02 of 2021 which issues a fatwa regarding the law that the Covid-19 vaccine produced by Sinovac Life Sciences Co. Ltd. China and PT. Bio Farma (Persero) is legal, holy and halal. This study aims to find out in detail the legal basis for the MUI to issue a fatwa that the Sinovac vaccine is halal and to know and be able to analyze the views of Islamic law on the MUI Fatwa No. 02 of 2021 regarding the halalness of the Sinovac vaccine. This research is legal-normative research, namely research that uses law to justify a legal event. This type of research is descriptive-analytic research using library research. Based on the results of the study, it is known that there are 7 basics used by the MUI in determining the halalness of the Sinovac vaccine, namely: First, the opinion of the Ulama; Second, MUI Fatwa No. 04/2016 on Immunization; Third, MUI Fatwa Number 01 of 2010 concerning the Use of Microbes and Microbial Products in Food Products; Fourth, MUI Fatwa Number 45 of 2018 concerning the Use of Blood Plasma for Medicinal Ingredients; Fifth, the report and explanation of the audit results of the LPPOM MUI Auditor Team together with the MUI Fatwa Commission to Sinovac and PT Bio Farma; Sixth, the opinion of the participants of the Fatwa Commission meeting on January 8, 2021; Seventh, BPOM's decision to give approval for emergency use and guarantee of safety, quality, and efficacy for the Sinovac vaccine, which is one indicator that the vaccine meets thayyib qualifications. In addition, it can be believed that the Covid-19 vaccine produced by Sinovac is holy and halal. Those are the notes on the results of the MUI Fatwa regarding the halal certification of vaccines that were described in the Plenary Session of the MUI Fatwa Commission on January 8, 2020 and the MUI Fatwa No. 2 of 2021 has been issued/decided.
Downloads
References
Arifianto, Yakin Dengan Vaksin dan Imunisasi?, (Depok: Kata Depan, 2019)
Azwar Iskandar, Peran Ekonomi dan Keuangan Sosial Islam saat Pandemi Covid-19 - Dalam Jurnal Sosial dan Budaya SyarI, Vol. 7, No. 7
Emma Ratna Sari Meody, Tinjauan Budaya Pidato Presiden Joko Widodo Pasca Vaksinasi Pertama Di Indonesia - Jurnal Cakrawati, Vol.4 No.01, 2021, hlm. 22.
Farhat Abdullah, Kontroversi Kehalalan Vaksin Sinovac: Menurut Masyarakat Awam - Jurnal Pendidikan Islam, Vol. 4, No. 01, 2021.
Keputusan Menteri Kesehatan Republik Indonesia No. HK. O1.07/MENKES/9820/2020 Tentang Penetapan Jenis Vaksin Untuk Vaksinasi Corona Virus Disease 2019 (Covid-19).
Keputusan Presiden Republik Indonesia Nomer 12 Tahun 2020 Tentang Penetapan Bencana Nonalam Penyebaran Corona Virus Disease 2019 (Covid-19), 2020
Nur Sholikah Putri Suni, Kesiapsiagaan Indonesia Menghadapi Potensi Penyebaran Corona Virus Disease, Bidang Kesejahteraan Sosial Info Singkat Kajian Singkat Terhadap Isu Aktual Dan Strategis,Vol.XII.No.3, 2020, hlm. 14.
Nurul Zuriah, Metodelogi Penelitian Sosial dan Pendidikan,( Jakarta: Bumi Aksara, 2009)
Oscar Primadi, Inilah Upaya Negara Melindungi Generasi Bangsa Dari Ancaman Penyakit Berbahaya - Sehat Negeriku, Senin, 2018. Diakses 20 Desember 2021). https://sehatnegeriku. kemkes.go.id/baca/rilis-media/20180129/1824335/inilah-upayanegara-melindungi-generasi-bangsa-ancaman-penyakit-berbahaya/.
Perhimpunan Dokter Paru Indonesia, Jurnal Respirologi Indonesia: Majalah Resmi Perhimpunan Dokter Paru Indonesia, Vol.40. No.2, April, 2020
Piprim B Yanuarso, Kontroversi vaksin Pilihan Terbaik Bagi Buah Hati Tanpa Ragu lagi, (Bandung: Qanita, 2019)
Soejono Soekanto, Pengantar Penelitian Hukum, (Jakarta: UI Press, 2006)
Tiyas Septiana, Pengertian Vaksin dan Cara Kerja Terhadap Tubuh, https://kesehatan.kontan.co. id/ news/pengertian-vaksin-dan-cara-kerjanya-terhadap-tubuh. Diakses pada tanggal 20 Desember 2021.
Wahyu Purhantara, Metode Kualitatif untuk Bisnis, (Yogyakarta: Graha Ilmu, 2010)
Yusak Alvian dan Steven Laundry, Propaganda Covid-19 Terhadap Awareness Masyarakat Surabaya Untuk Mengikuti Program Kerja Pemerintah, Jurnal Komunikasi Profesional, Vol.4 No.1, 2020
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal right of first publication and this work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
All articles in this journal may be disseminated by listing valid sources and the title of the article should not be omitted. The content of the article is liable to the author.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
In the dissemination of articles, the author must declare the JURNAL ILMIAH MAHASISWA FAKULTAS HUKUM UNIVERSITAS MALIKUSSALEH as the first party to publish the article.
